Search - tctmd.com

Displaying 801 - 820 of 1206

Sort: Relevancy | Date

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Industry News

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

October 30, 2013

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Presentation TCT 2013

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Presenter: Soo-Jin Kang

October 29, 2013

Presentation TCT 2013

Case Presentation 1: A Long-Run Restenosis Tale

Presenter: Marin Postu

October 29, 2013

News Conference News TCT 2013

Paclitaxel-Coated Balloons Show Promise in Two Studies

October 29, 2013

News Industry News

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

October 29, 2013

Presentation TCT 2013

Restenosis and Stent Thrombosis

Presenter: Kevin Croce

October 28, 2013

Presentation TCT 2013

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Presenter: John Ormiston

October 28, 2013

Presentation TCT 2013

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Presenter: Adrian Banning

October 28, 2013

Presentation TCT 2013

Predictors of Restenosis and Reocclusion After Successful CTO PCI in the DES Era: Insights from the Florence CTO Registry

Presenter: David Antoniucci

October 28, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Presentation TCT 2013

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Presenter: Robert Byrne

October 28, 2013

Presentation TCT 2013

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

DES Restenosis: Evaluation and Treatment Options

Presenter: Fernando Alfonso

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Presenter: Thomas Zeller

October 27, 2013

Presentation TCT 2013

Attacking the Adventitia: Rationale, Feasibility, and Early Signals of Efficacy for Restenosis

Presenter: Christopher Owens

October 27, 2013

News Daily News

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Leah Lawrence

October 25, 2013

Advertisement

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Case Presentation 1: A Long-Run Restenosis Tale

Paclitaxel-Coated Balloons Show Promise in Two Studies

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

Restenosis and Stent Thrombosis

Longitudinal Stent Deformation and Strut Fracture: Common Causes of Restenosis and Stent Thrombosis?

Restenosis after Left Main PCI: Frequency, Patterns and Treatment (with Case Vignettes)

Predictors of Restenosis and Reocclusion After Successful CTO PCI in the DES Era: Insights from the Florence CTO Registry

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Frequency and Time Course of DES Restenosis and Stent Thrombosis: Latest Insights from Randomized Trials and the "Real World"

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

DES Restenosis: Evaluation and Treatment Options

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Attacking the Adventitia: Rationale, Feasibility, and Early Signals of Efficacy for Restenosis

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content